Trabanco-Suárez, Andrés,Cid-Núñez, José,Lavreysen, Hilde,Ceusters, Marc André,Klein, Brian,Pype, Stefan,Twyman, Roy,Van Osselaer, Nancy,White, H.,Bone, Roger
申请号：
NZ72238515
公开号：
NZ722385A
申请日:
2015.01.20
申请国别(地区):
NZ
年份:
2019
代理人:
摘要：
The present invention relates to a combination comprising (a) a synaptic vesicle protein 2a (“SV2A”) ligand selected from the group consisting of levetiracetam, brivaracetam and seletracetam； and (b) a positive allosteric modulator of the metabotropic glutamatergic receptor subtype 2 selected from a compound having a Formula as shown in the abstract drawing or a pharmaceutically acceptable salt or a solvate thereof.
